0 items USD 0.00Search
- Did you mean
- bruton’s tyrolit kinase
Your search for "Bruton's tyrosine kinase" gave back 65334 results.
Ibrutinib is an orally bioavailable, small-molecule inhibitor of Bruton's tyrosine kinase (BTK) with potential antineoplastic activity. Upon...
Catalog:
MRRPB5
May 2023
Price: USD 2,900.00
Ibrutinib is an orally bioavailable, small-molecule inhibitor of Bruton's tyrosine kinase (BTK) with potential antineoplastic activity. Upon...
Catalog:
MRRPB5
July 2023
Price: USD 4,900.00
Zanubrutinib is a potent and covalent inhibitor of Bruton's tyrosine kinase. The global Zanubrutinib market was valued at US$ million in 2023...
Catalog:
MRRPB5
February 2024
Price: USD 2,900.00
Zanubrutinib is a potent and covalent inhibitor of Bruton's tyrosine kinase. The global Zanubrutinib market was valued at US$ million in 2022...
Catalog:
MRRPB5
February 2023
Price: USD 2,900.00
Zanubrutinib is a potent and covalent inhibitor of Bruton's tyrosine kinase. According to our Publisher latest study, the global Zanubrutinib...
Catalog:
GIR
February 2023
Price: USD 3,480.00
Zanubrutinib is a potent and covalent inhibitor of Bruton's tyrosine kinase. The global Zanubrutinib market is projected to grow from US$...
Catalog:
MRRPB5
July 2023
Price: USD 4,900.00
Quizartinib is a small molecule receptor tyrosine kinase inhibitor. The global Quizartinib market was valued at US$ million in 2023 and is...
Catalog:
MRRPB5
February 2024
Price: USD 2,900.00
Quizartinib is a small molecule receptor tyrosine kinase inhibitor. The global Quizartinib market was valued at US$ million in 2022 and is...
Catalog:
MRRPB5
May 2023
Price: USD 2,900.00
Quizartinib is a small molecule receptor tyrosine kinase inhibitor. The global Quizartinib market is projected to grow from US$ million in 2023 to US...
Catalog:
MRRPB5
June 2023
Price: USD 4,900.00
Radotinib is a tyrosine kinase inhibitor. The global Radotinib market was valued at US$ million in 2023 and is anticipated to reach US$ million by...
Catalog:
MRRPB5
February 2024
Price: USD 2,900.00
Radotinib is a tyrosine kinase inhibitor. The global Radotinib market was valued at US$ million in 2022 and is anticipated to reach US$ million by...
Catalog:
MRRPB5
May 2023
Price: USD 2,900.00
Radotinib is a tyrosine kinase inhibitor. The global Radotinib market is projected to grow from US$ million in 2023 to US$ million by 2029, at a...
Catalog:
MRRPB5
June 2023
Price: USD 4,900.00
Momelotinib, an aminopyrimidine derivative discovered by high-throughput enzyme and cell-based screening along with the optimization using structure-...
Catalog:
MRRPB5
February 2024
Price: USD 2,900.00
Momelotinib, an aminopyrimidine derivative discovered by high-throughput enzyme and cell-based screening along with the optimization using structure-...
Catalog:
MRRPB5
February 2023
Price: USD 2,900.00
Momelotinib, an aminopyrimidine derivative discovered by high-throughput enzyme and cell-based screening along with the optimization using structure-...
Catalog:
GIR
February 2023
Price: USD 3,480.00
